Prime Highlights
- The Madras Diabetes Research Foundation (MDRF) has partnered with the Centre for Brain Research (CBR) at IISc Bengaluru and the UK Dementia Research Institute (UK DRI) to explore how diabetes contributes to brain disorders such as dementia and Alzheimer’s disease.
- The collaboration aims to uncover biological mechanisms connecting metabolic dysfunction and cognitive decline, paving the way for early detection and better treatment strategies.
Key Facts
- The research will combine clinical, imaging, genomic, and proteomic data to identify pathways linking diabetes and brain function.
- The initiative involves top experts, including Dr. V. Mohan, Dr. R. M. Anjana, Prof. K. V. S. Hari, Prof. Siddharthan Chandran, and Prof. Henrik Zetterberg, representing India, the UK, and Sweden.
Background
The Madras Diabetes Research Foundation (MDRF) in Chennai has teamed up with the Centre for Brain Research (CBR) at the Indian Institute of Science (IISc), Bengaluru, and the UK Dementia Research Institute (UK DRI) to study how diabetes affects brain health and leads to disorders like dementia and Alzheimer’s disease.
This partnership brings together top experts in diabetes, brain science, and dementia to find out how metabolic problems cause memory loss and other brain issues.
Dr. V. Mohan, Chairman of MDRF, said the collaboration marks an important step in understanding how diabetes affects both the body and the brain. “By joining hands with top neuroscientists, we aim to discover mechanisms that can improve life for millions,” he said.
Dr. R. M. Anjana, President of MDRF, added that diabetes is now seen as a risk factor for dementia. “This partnership will help us use diverse datasets to identify early brain aging markers and guide future treatments,” she said.
Prof. Siddharthan Chandran, Director of UK DRI, called it “a crucial step” toward solving how metabolic disorders influence brain function. Prof. K. V. S. Hari, Director of CBR, highlighted that the research will integrate clinical, imaging, genomic, and proteomic data to find pathways linking diabetes and cognition.
Prof. Henrik Zetterberg, UK DRI and University of Gothenburg, said the study would help develop new intervention strategies by combining insights from metabolic and brain research.
